SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/1B2C7EFAE584A3A9E3CB22A422E7896A374961B1D447E51C38437CDAE8D9CB97B35CCB8AFE0B3BB405A889B8E99D30AB>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/1B2C7EFAE584A3A9E3CB22A422E7896A374961B1D447E51C38437CDAE8D9CB97B35CCB8AFE0B3BB405A889B8E99D30AB
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/1B2C7EFAE584A3A9E3CB22A422E7896A374961B1D447E51C38437CDAE8D9CB97B35CCB8AFE0B3BB405A889B8E99D30AB
http://www.w3.org/2000/01/rdf-schema#comment
"This study revealed the anti-angiogenic activity of metformin in ELT-3 cells by suppressing the expression of VEGF via the mTORC1/HIF-1alpha pathway."
xsd:string
http://purl.uniprot.org/uniprot/#_FEE83137AB6B41B0DD5AE3BA232FA9D68FF80CD89D68C94FA9EB6E3727E45B7555CBF4417E46A8F0650EBB9C545FB37A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/1B2C7EFAE584A3A9E3CB22A422E7896A374961B1D447E51C38437CDAE8D9CB97B35CCB8AFE0B3BB405A889B8E99D30AB
http://purl.uniprot.org/uniprot/B5DEK7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1B2C7EFAE584A3A9E3CB22A422E7896A374961B1D447E51C38437CDAE8D9CB97B35CCB8AFE0B3BB405A889B8E99D30AB
http://purl.uniprot.org/uniprot/#_B5DEK7-mappedCitation-25179820
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1B2C7EFAE584A3A9E3CB22A422E7896A374961B1D447E51C38437CDAE8D9CB97B35CCB8AFE0B3BB405A889B8E99D30AB